The Centers for Medicare & Medicaid Services (CMS) has unveiled comprehensive details regarding the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, a transformative initiative designed to expedite the availability of innovative medical technologies for Medicare beneficiaries. First introduced in April as a collaborative effort with the Food and Drug Administration (FDA), the […]
The American healthcare landscape is currently undergoing a significant technological transformation, driven by the rapid integration of artificial intelligence into the administrative and clinical workflows of major payers. In a recent detailed discussion on the MedCity Pivot Podcast, Nathan Frank, the Chief Digital and Technology Officer at Aetna, the insurance arm of CVS Health, outlined […]
The integration of artificial intelligence into the clinical workflow has reached a pivotal inflection point, moving beyond the initial novelty of digital scribing toward a more comprehensive automation of the healthcare administrative ecosystem. Ascension, one of the largest private healthcare systems in the United States, is currently spearheading a transition that seeks to eliminate the […]
The landscape of biotechnology initial public offerings has undergone a fundamental transformation in 2026, marking a definitive departure from the speculative frenzy that characterized the early 2020s. As the sector experiences a robust resurgence in public listings, a clear pattern has emerged: institutional investors are no longer content with preclinical promises. Instead, the market is […]
The biotechnology sector witnessed a significant influx of capital this week as two clinical-stage companies, Latigo Biotherapeutics and BlossomHill Therapeutics, successfully transitioned to the public markets, raising a combined total of nearly $500 million. The offerings underscore a revitalized investor appetite for specialized therapeutic platforms, specifically those addressing the urgent societal need for non-opioid pain […]
Despite an influx of more than $2.5 billion into kidney-focused value-based care initiatives over the last six years, hospital spending associated with kidney disease remains stubbornly high. This financial paradox suggests that while the volume of investment is significant, the strategic focus of these interventions may be misaligned with the actual drivers of inpatient costs. […]
The landscape of American employer-sponsored health insurance is undergoing a significant conceptual shift as a growing number of organizations evaluate the feasibility of Individual Coverage Health Reimbursement Arrangements (ICHRAs). According to a comprehensive new survey conducted by the Employee Benefit Research Institute (EBRI) with support from Morgan Health, approximately one-third of U.S. employers are currently […]
The U.S. Food and Drug Administration (FDA) has officially granted approval for mFLUSIVA, a messenger RNA (mRNA) influenza vaccine developed by Moderna, specifically for use in adults aged 50 and older. Announced late Wednesday, the decision marks a significant milestone in public health, introducing a new technological platform to the seasonal fight against the flu. […]
The 2026 INVEST Digital Health Conference, scheduled for October 29 at Pegasus Park in Dallas, arrives at a pivotal moment for the healthcare industry as it grapples with the transition from traditional provider-centric models to a consumer-first paradigm. Hosted in partnership with Health Wildcatters, the event aims to bridge the gap between clinical rigor and […]
Healthcare systems worldwide are currently navigating a paradox where the environments dedicated to healing have become increasingly volatile for the professionals providing care. Workplace violence in healthcare is no longer an occasional anomaly but a pervasive systemic challenge that threatens the stability of the global medical workforce. While many organizations have established protocols for responding […]
